| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | President and CEO
1 company
Christopher Richard Anzalone is Chief Executive Officer at ARWR. From March 2015 to January 2026, the filings on record show 0 open-market purchases and 37 sales. Christopher Richard Anzalone's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $225.8M at current prices.
Historically, Christopher Richard Anzalone's trades have earned a middling insider score of 60/100 across 27 rated trades. Over a 12-month horizon, 55.0% of those trades were profitable, with an average 12-month return of -24.1%.
The ARWR filings lean toward selling, a net 3,054,419 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 50,000 | $19.30 | $965,000.00 | -2.3% | |
| Dec 19, 2018 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 90,000 | $13.92 | $1,252,800.00 | -5.5% | |
| Dec 12, 2018 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 90,000 | $14.07 | $1,266,300.00 | -5.2% | |
| Nov 9, 2018 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 81,500 | $14.39 | $1,172,705.00 | -4.5% | |
| Sep 4, 2018 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 164,834 | $14.45 | $2,381,851.30 | -8.4% | |
| Mar 16, 2018 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 26,000 | $7.40 | $192,400.00 | -1.3% | |
| Mar 15, 2018 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 300,000 | $7.43 | $2,228,000.00 | -13.1% |